Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Name: Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
Published: 2001
License: Public Domain

EMD Serono · 2001

ClinicalTrials.gov · Datasets · License: Public Domain · 2001

Open Source ↗

humanimmunodeficiencyvirus placebo

human immunodeficiency virus-associated adipose redistribution syndrome (hars), human immunodeficiency virus infections, recombinant human growth hormone (r-hgh), serostim®, placebo, interventional, phase2, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Related documents